Tocqueville Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Tocqueville Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-80,000	Closed	-$695K	–	985
2014 Q3	$695K	Sell	80,000 -12,000	-13%	-$108K	0.01%	560
2014 Q2	$1.01M	Sell	92,000 -12,500	-12%	-$111K	0.01%	572
2014 Q1	$934K	Sell	104,500 -1,000	-0.9%	-$9.21K	0.01%	462
2013 Q4	$795K	Hold	105,500	–	–	0.01%	485
2013 Q3	$773K	Buy	105,500 +42,500	+67%	+$285K	0.01%	551
2013 Q2	$405K	Buy	+63,000	New	+$371K	0.01%	692

Other funds holding SUPN

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

MRM

Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MOACM

Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return

Tocqueville Asset Management's SUPN Position: Q4 2014 in Review

Tocqueville Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q4 2014, closing a stake of 80,000 shares — an estimated $695K sold.

Tocqueville Asset Management first reported a position in SUPN in Q2 2013 and held it in 6 quarters. The position peaked at $1.01M in Q2 2014. 107 funds tracked by Wall St. Rank hold SUPN as of Q4 2014.

Tocqueville Asset Management reported no remaining Supernus Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
Tocqueville Asset Management sold 80,000 Supernus Pharmaceuticals shares in Q4 2014, an estimated $695K.
Tocqueville Asset Management first reported a position in Supernus Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Tocqueville Asset Management's Supernus Pharmaceuticals position peaked at $1.01M in Q2 2014.
107 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2014.

Based on Tocqueville Asset Management's 13F filing for Q4 2014, filed 30 Jan 2015.